GANNON STEVEN sold 0.0% of their position (3.00 shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $91.44 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/6/2025ACC: 0000950170-25-083321
+19.65K
Net shares
Net buyer
$91.44
Total sold
1
Open market trades
0B · 1S
3
Total transactions
19.66K acquired · 3.00 disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−3.00
Price / share
$30.48
Trade value
$91.44
% of position
0.0%
6/5/2025
7.14K→7.14K
Total
Net shares
−3.00
Net value
-$91.44
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/5/2025 | S · Sale | −3.00 | $30.48 | $91.44 | 0.0% | 7.14K | 7.14K |
| Total | −3.00 | -$91.44 | ||||||
Derivative Transactions2
Share Option (Right to Buy)
Direct
Converts to
Common Shares
17.01K shares
Shares
+17.01K
Strike price
30.73
Held after
17.01K
Exercisable
—
6/5/2025
Restricted Share Units
Direct
Converts to
Common Shares
2.65K shares
Shares
+2.65K
Strike price
0
Held after
2.65K
Exercisable
—
6/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Common Shares17.01K shares | 6/5/2025 | A · Award | +17.01K | 30.73 | — | 17.01K |
| Restricted Share Units Direct | Common Shares2.65K shares | 6/5/2025 | A · Award | +2.65K | 0 | — | 2.65K |